Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP011/AS01B Malaria Vaccine Phase I/IIa
NCT00312663Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Apr 2006
- Primary completion
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of FMP011 in Plasmodium falciparum malaria, sponsored by U.S. Army Medical Research and Development Command. Started Apr 2006; status: completed.
02
Drugs
FMP011
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00312663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312663.